Viewing data from:

MERZEE

ANDA

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE | A212706 | WILSHIRE PHARMACEUTICALS INC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: TAYTULLA(TE code: AB)

Medicare Part D Spending

CMS annual spending data for Merzee (2023)

Total Spending

$3K

Total Claims

Beneficiaries

—

Avg Cost/Unit

$3.35

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.02MG;1MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Dec 18, 2020

No patent or exclusivity listings for this strength.